You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Profit from the Pros By Kevin Matras Executive Vice President
Stocks Fell On Friday On New Covid Variant Concerns
Stocks sank on Friday after reports that a new Covid variant was spreading fast in South Africa.
The new strain, which the World Health Organization (WHO) has dubbed 'omicron,' has labeled it a "variant of concern."
It will take weeks to understand the severity of this new variant. But the big fear is that it might be more transmissible, and have greater resistance against the vaccines.
As such, strong precautions are being taken to restrict travel to and from South Africa. This includes the U.S., along with the U.K., Germany, France, Italy and others. All in all, roughly a dozen countries have imposed restrictions. And that list is likely to grow.
The world economy has been rebounding strongly, especially the U.S., as pandemic restrictions had loosened and life was slowly starting to get back to something closer to normal.
If restrictions begin to tighten again, that could negatively impact the recovery. That, of course, would further aggravate supply chain disruptions, and exacerbate inflation.
Friday's price action was clearly a case of "sell first and ask questions later." And the day's volatility was only magnified by the shortened trading hours and thinner post-holiday trading conditions.
In the coming days and weeks, we'll get a better sense of where we are in the fight against omicron, including whether the vaccines are an effective guard against it.
On the bright side, vaccine makers Pfizer and BioNTech, have said if adjustments are needed to combat this new strain, they were confident they could create a new one within 6 weeks and make/ship it out within 100 days.
In the meantime, we could see more volatility until more is known.
At the moment, there are no signs of the omicron variant in the U.S.
And from an economic standpoint, our economy is expected to accelerate into the end of the year.
With December typically being a strong month for stocks, that bodes well for the market.
But the omicron variant will be the new wildcard for the next couple of weeks at least.
See you tomorrow,
Executive Vice President, Zacks Investment Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »
Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.
Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.
Get all of our market insights and much more when you connect with us.
This free resource is being sent by Zacks.com. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through November 1, 2021. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed above.
Zacks Emails If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email email@example.com.
Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606
Due to inactivity, you will be signed out in approximately: